BlackRock Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$67K Buy
5,186
+1,264
+32% +$19.5K ﹤0.01% 3178
2016
Q3
$64K Buy
3,922
+680
+21% +$12.3K ﹤0.01% 3182
2016
Q2
$40K Buy
3,242
+1,345
+71% +$16.8K ﹤0.01% 3277
2016
Q1
$20K Hold
1,897
﹤0.01% 3432
2015
Q4
$28K Buy
+1,897
New +$23.2K ﹤0.01% 3393

Other funds holding MYOK

BlackRock Advisors's MYOK Position: Q4 2016 in Review

BlackRock Advisors increased its MyoKardia, Inc. Common Stock (MYOK) stake by 32% in Q4 2016, buying an estimated $19.5K and bringing the position to 5,186 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #3178.

BlackRock Advisors first reported a position in MYOK in Q4 2015 and has held it in 5 quarters since. 71 funds tracked by Wall St. Rank hold MYOK as of Q4 2016.

  • BlackRock Advisors held 5,186 shares of MyoKardia, Inc. Common Stock worth $67K as of Q4 2016.
  • BlackRock Advisors bought 1,264 MyoKardia, Inc. Common Stock shares in Q4 2016, an estimated $19.5K.
  • MyoKardia, Inc. Common Stock made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3178 holding.
  • BlackRock Advisors first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and has held it in 5 quarters since.
  • 71 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.